Jeff Stec is a panelist on this topic. They will provide an in-depth analysis of the significant issues and recent updates with regard to Trademark and False Advertising Litigation. Speakers will present best practices and practical tips to avoid unnecessary risks and pitfalls.
For more information on this event, click here.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...